Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine the effectiveness of various combinations of psychosocial therapy and risperidone treatment in improving work or school performance in people with first-episode schizophrenia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of California, Los Angeles
• Collaborators: Janssen Scientific Affairs, LLC; National Institute of Mental Health (NIMH)
• Treatments: Risperidone

Criteria

Inclusion Criteria:

• Diagnosis of schizophrenia, schizoaffective disorder (depressed type), or schizophreniform disorder

• First major episode of psychotic symptoms occurred within 2 years prior to study entry

Exclusion Criteria:

• Neurological disorder or injury (e.g., encephalitis, epilepsy, traumatic brain injury)

• Mental retardation (e.g., premorbid intelligence quotient (IQ) less than 70)

• Significant alcohol or substance use during last 6 months

• Unable to complete research measures in English

• Any condition that may make risperidone use medically inadvisable